US FDA approves DermaSensor device to detect skin cancer with AI
Privately held device maker DermaSensor said Wednesday that the U.S. Food and Drug Administration has cleared its handheld device that uses artificial intelligence to detect skin cancer.
POPULAR POSTS
Earthquakes and emissions undermine the idea of carbon storage in Texas
December 17, 2024
Rescuers search for cyclone survivors in devastated Mayotte
December 17, 2024
“Gilmore Girls” airs for a second season on Hulu
December 17, 2024
LIVE STREAM